Skip to content
Menu
New Options

You Deserve a Better Life

Have you or a loved one received a diagnosis of Peripheral Artery Disease (PAD) or Chronic Limb-Threatening Ischemia (CLTI)? PAD and CLTI are serious conditions that can threaten both life and limb.

Living with PAD that progresses to CLTI can be extremely challenging. Chronic leg pain and non-healing wounds are debilitating, and conventional treatments may no longer be effective, leaving amputation as the only option for end-stage patients.

It may be difficult to imagine life without the use of a limb that has been a part of you for so long. But there is hope – ask your doctor about the LimFlow System and take the first step towards a brighter tomorrow.

CLTI – the Most Severe Form of Peripheral Arterial Disease

CLTI Patient
3.8M Square
In the U.S. affected by Chronic Limb-Threatening Ischemia (CLTI) and the number continues to grow1
150K Square
Major lower extremity amputations in the U.S. annually2
4x Square
More likely to face major amputation if you are Black3
6th Square
Most expensive surgical procedure in the U.S. = Major Amputation4

Driven by high complication rates, length of stay, readmissions, and hospitalizations

About LimFlow Therapy

Before LimFlow

Patients

After LimFlow

Patients

The LimFlow system is a breakthrough treatment that can restore blood flow to your affected limb and give you a chance at a better future. With this groundbreaking solution, you can keep your limb and potentially avoid a lifetime of limitations.

Find a Doctor and Take Charge

Use our locator to find a doctor who is experienced using the LimFlow System to treat appropriate patients with late-stage CLTI

Site NameSite LocationPhysician
Atrium HealthCharlotte, North CarolinaGregory Stanley
Baylor College of MedicineHouston, TexasJoseph Mills
Boston Medical CenterBoston, MassachusettsAlik Farber
Coastal Carolina Surgical AssociatesWilmington, North CarolinaDavid Weatherford
Dartmouth – Hitchcock Medical CenterLebanon, New HampshireRichard Powell
Harbor-UCLA Medical CenterTorrance, CaliforniaMark Archie
Massachusetts General HospitalBoston, MassachusettsAnahita Dua
Ochsner Health CenterNew Orleans, LouisianaZola N’Dandu
Presbyterian Healthcare ServicesAlbuquerque, New MexicoSteve Henao
Prisma Health-USC Medical GroupGreenville, South CarolinaSagar Gandhi
San Lucas HospitalPonce, Puerto RicoJorge Martinez Trabal
The Cardiac and Vascular Institute Research FoundationGainesville, FloridaArthur Lee
University Hospitals Harrington Heart & Vascular InstituteCleveland, OhioMehdi Shishehbor
University of California, San FranciscoSan Francisco, CaliforniaMichael Conte
University of FloridaGainesville, FloridaBen Jacobs
Vanderbilt University Medical CenterNashville, TennesseePatrick Stone
Yale UniversityNew Haven, ConnecticutCassius Chaar

Hear From Patients

Listen to the experiences of other patients who had lost hope until their doctor recommended treatment with the innovative LimFlow System.

Sources:
  1. Yost ML. CLI US epidemiology supplement 2016. THE SAGE GROUP.
  2. Creager MA, Matsushita K, Arya S, Beckman JA, Duval S, Goodney PP, Gutierrez JAT, Kaufman JA, Joynt Maddox KE, Pollak AW, Pradhan AD, Whitsel LP. Reducing Nontraumatic Lower-Extremity Amputations by 20% by 2030: Time to Get to Our Feet: A Policy Statement From the American Heart Association. Circulation. 2021 Apr 27;143(17):e875-e891.
  3. Estimated U.S. hospital procedure Cost including stay (excluding LF system) based on cost estimates from clinical data collected in PROMISE II IDE Pivotal Study cross walked to corresponding cost data from Liberty 360 Economic Study Supplement and U.S. hospital CFO feedback.
  4. Yost ML. Cost-Benefit Analysis of Critical Limb Ischemia in the Era of the Affordable Care Act. 2014. Endovascular Today